NEOVASCULAR GLAUCOMA
Clinical trials for NEOVASCULAR GLAUCOMA explained in plain language.
Never miss a new study
Get alerted when new NEOVASCULAR GLAUCOMA trials appear
Sign up with your email to follow new studies for NEOVASCULAR GLAUCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Eylea eyed as treatment for glaucoma caused by abnormal blood vessels
Disease control Recruiting nowThis study is tracking 480 people with neovascular glaucoma, a serious eye condition, who are receiving the drug Eylea (aflibercept) as part of their normal care. Researchers are monitoring side effects and how well the drug controls eye pressure and vision over 6 months. The goa…
Matched conditions: NEOVASCULAR GLAUCOMA
Sponsor: Bayer • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Eye scan may spot hidden blood-flow changes that signal glaucoma risk in diabetes
Knowledge-focused Recruiting nowThis observational study uses a painless, non-invasive eye scan called iris OCTA to measure blood flow in the iris of people with type 2 diabetes. Researchers want to see if blood-flow patterns differ between healthy eyes, diabetic eyes without complications, and those with diabe…
Matched conditions: NEOVASCULAR GLAUCOMA
Sponsor: Qilu Hospital of Shandong University • Aim: Knowledge-focused
Last updated Jul 30, 2026 00:00 UTC